Pablo has over 25 years of experience in biotech, including 12 years as Chief Medical Officer, experience in neuroscience, and a record of drug approvals. He was previously CMO at Lexicon Pharmaceuticals, VP of Clinical Development at Bristol-Myers Squibb, and CMO at Cogentus Pharmaceuticals. He has published in both the New England Journal of Medicine and the Wall Street Journal. His MD and BA are from Harvard University.

Ben was CEO/Co-founder of Firecracker, an adaptive learning healthcare platform acquired by Wolters Kluwer (Euronext: WKL). He was also CEO/Founder of Firefly Health, an online support community for patients with 40,000+ members. He was also Executive Director of the Foundation for International Medical Relief of Children (FIMRC), a nonprofit providing health care to millions of children worldwide. His B.A. is from Harvard College.

Associate Professor of Neurology at Harvard Medical School, Associate Neuroscientist at Massachusetts General Hospital, and Director of the MGH Chemical Neurobiology Laboratory. Dr. Haggarty is also a Senior Associate Member of the Broad Institute of Harvard & MIT and Affiliate Faculty Member of the Harvard Stem Cell Institute. His research has identified the mechanism of action of lithium in treating bipolar disorder.

Director, the Picower Institute for Learning and Memory at MIT. Picower Professor of Neuroscience, department of Brain and Cognitive Sciences. Senior Associate member, Broad Institute. Dr. Tsai is a leader in the study of biological pathways involved in Alzheimer's disease and other neurological disorders.

Randy is a world leader in regenerative medicine. He is Professor emeritus at the University of Washington where he founded the institute for Stem Cell research and Regenerative Medicine. He has hundreds of publications and is a member of both the American Academy of Arts & Sciences and the National Academy of Sciences. He was senior scientific cofounder of Fate Therapeutics, which has made important progress in the treatment of cancer.

Alan is Founder and Principal of the Prestar Group and has >30 years of life sciences experience. He has served as CFO and advisor to numerous companies including Karyopharm Therapeutics, Forma Therapeutics, Foundation Medicine, Marinus Pharmaceuticals, Durata Therapeutics and Repligen. He has assisted in raising more than $500 million in development and growth capital in the private and public financial markets (including IPOs)

Don has held multiple board and senior executive positions. He has been President of Global Pharmaceuticals at Bristol-Myers Squibb and served as Board Chairman at REGENXBIO, Amicus Therapeutics, Insmed, Vitae Pharmaceuticals, Gloucester Pharmaceuticals, and WindMIL Therapeutics. He is Chairman of Otsuka America Pharmaceuticals Incorporated and Avanir Pharmaceuticals. His M.B.A. is from Indiana University and his B.A. from Harvard University.

Larry has expertise in biology, genetics, and neuroscience. He was a Full Professor at Harvard in Cell and Developmental Biology. He is currently a Professor Emeritus of Cellular and Molecular Medicine and Neuroscience at UC San Diego and Scientific Director of the Sanford Consortium for Regenerative Medicine. Larry co-founded Cytokinetics. He is a member of the American Academy of Arts and Sciences and the National Academy of Sciences.

Kim has over 20 years of biotechnology industry and Wall Street experience with expertise in capital markets, strategic corporate finance, corporate communications, and investor relations. Her prior experience includes Chief Corporate Affairs Officer at Taysha Gene Therapies. Kim received her B.S. from Stanford University and medical degree from Kirksville College of Osteopathic Medicine.

Marcella is a seasoned life sciences executive with diverse successes within the corporate sphere and along the integrated drug development continuum. Previously, she was the Senior Vice President of Operations and Portfolio Management at Sumitovant Biopharma. Marcella serves as a Product Advisory Board member at Lokavant and an Adjunct Professor at Campbell University. Marcella has a BS, MBA and MS from the University of Wisconsin-Madison.